LUT014 for the Treatment of Radiation Induced Dermatitis in Breast Cancer Patients

Clinical trial NCT04261387 · COMPLETED

Trial details

NCT number: NCT04261387
Sponsor: Lutris Pharma Ltd.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Radiation Dermatitis

Start date: 2021-01-30
Primary completion: 2022-06-16
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.